Bayer donates 3 million tablets of investigational coronavirus drug Resochin to the US
federal agencies continue to investigate possible treatment options for the novel coronavirus, pharmaceutical company Bayer announced on Thursday that it is donating 3 million tablets of its antimalarial drug chloroquine phosphate to the US government.
Sharing details first with CNN, Bayer said in a statement that chloroquine phosphate, sold under the name Resochin, originally has been indicated for the prevention and treatment of malaria, but also appears to have “broad spectrum antiviral properties” and effects on the body’s immune response.
“New data from initial preclinical and evolving clinical research conducted in China, while limited, shows potential for the use of Resochin in treating patients with COVID-19 infection,” the statement said.
federal agencies continue to investigate possible treatment options for the novel coronavirus, pharmaceutical company Bayer announced on Thursday that it is donating 3 million tablets of its antimalarial drug chloroquine phosphate to the US government.
Sharing details first with CNN, Bayer said in a statement that chloroquine phosphate, sold under the name Resochin, originally has been indicated for the prevention and treatment of malaria, but also appears to have “broad spectrum antiviral properties” and effects on the body’s immune response.
“New data from initial preclinical and evolving clinical research conducted in China, while limited, shows potential for the use of Resochin in treating patients with COVID-19 infection,” the statement said.